1-Methyl-4-(4-methylpiperidin-4-yl)piperazine trihydrochloride, 95+%, 250mg

(1S,2S,5R)-3-(tert-Butoxycarbonyl)-3-azabicyclo[3.1.0]hexane-2-carboxylic acid, 95.0%, 5g

Ocular HWF 10x/22 mm con punto de mira

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-aspartic Acid>98.0%(HPLC)(T)25g

1-(1-Methylethyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 1g

2-(4-Bromopyridin-2-yl)propan-2-ol, 95.0%, 5g

3-Amino-2-methylpropanoic acid, 97.0%, 5g

2-Iodopropane, 99.0%, 500g

3,5-dimethyl-1-(1H-1,2,3,4-tetrazol-5-yl)-1H-pyrazol-4-amine, 95%, 5g

3-Amino-2,6-difluorobenzonitrile, 95.0%, 5g

H-D-Orn.HCl, 98.00%, 5g

5-Methyl-2-(prop-1-en-2-yl)hex-4-en-1-ol, 1g

3-Fluoro-2-formylphenylboronic Acid (contains varying amounts of Anhydride)5g